As expected, in subcutaneous tumor models, macrophage TgMGLL largely potentiated mRNA levels of TNFα, IL-6, and IFNγ in tumor-associated CD8+ T cells, and this effect was prevented by additional macrophage TgCB2 (Fig. 6a). This evidence concerns the gene CD8A and neoplasm.